OncoMed Pharmaceuticals Inc. buy melinda
Start price
14.04.17
/
50%
€3.48
Target price
22.08.17
€7.67
Performance (%)
10.88%
End price
22.08.17
€3.86
Summary
This prediction ended on 22.08.17 with a price of €3.86. The BUY prediction by melinda finished with a performance of 10.88%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| OncoMed Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by melinda for this prediction
In the thread OncoMed Pharmaceuticals Inc. diskutieren
es sollte funktionieren
$ 4.84
0,12 (+ 2,54%) Tarextumab - PINNACLE Studie Lungenkrebs, kleinzelliger
OMED
Stopped prediction by melinda for OncoMed Pharmaceuticals Inc.
OncoMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.88
17.03.19
17.03.19
€1.13
25.04.19
25.04.19
-8.72%
25.04.19
25.04.19
OncoMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.71
24.10.18
24.10.18
€2.16
22.01.19
22.01.19
-58.25%
22.01.19
22.01.19
OncoMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.21
04.01.17
04.01.17
€9.02
27.02.17
27.02.17
25.78%
27.02.17
27.02.17
OncoMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.13
04.12.13
04.12.13
€19.00
04.06.14
04.06.14
0.00%
04.06.14
04.06.14